Lifecore Biomedical Inc
NASDAQ:LFCR
| Market Cap (Intraday) | 284.30M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.51 |
| 50-Day MA | $7.64 |
| 200-Day MA | $6.86 |
Lifecore Biomedical Inc Stock, NASDAQ:LFCR
3515 Lyman Boulevard, Suite 232, Chaska, Minnesota 55318
United States of America
Phone: +1.952.368.4300
Number of Employees: 524
Description
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.